The authorities proclaims a 5% discount in drug reimbursement in 2025 | EUROtoday

HASGoing to the physician or pharmacist will quickly price extra. The reimbursement charge for medicines by Social Security will drop by 5% subsequent yr, as will the protection of medical consultations, introduced the Minister of Health, Geneviève Darrieussecq, this Monday, November 18, within the Senate.

The “moderation fee”, most frequently the duty of supplementary medical insurance, “will only change by 5%” for medical consultations, whereas “it was potentially possible to increase it by 10%”, however “in complement [celui] on medicines will increase by 5%,” stated the minister on the opening of the debates on the Social Security financing invoice for 2025.

These dereimbursements, which don’t seem within the textual content however which can be recorded by ministerial decree, will end in a “transfer to complementary health insurance” whose quantity “has been reduced from 1.1 billion to 900 million euros,” he stated. -she clarified.

“Slippage” in drug spending

The authorities’s preliminary mission consisted of lowering the price of medical consultations from 70% to 60%, which can subsequently be reimbursed at 65% sooner or later. For medicines, the three present reimbursement charges (65%, 30% and 15%) would a priori be lowered in the identical proportion.

In addition, to realize a financial savings goal of “up to 5 billion euros” on well being spending, “we are also considering price reductions for health products amounting to 1.2 billion euros”, in addition to “efficiency measures at the hospital” for 600 million and in addition on metropolis take care of 600 million, added Geneviève Darrieussecq.ALSO READ Budget 2025: a (slight) brake on medical insurance spending

Furthermore, the Minister of Health confirmed the shock slippage in drug spending, revealed Sunday night by The Echoes“valued at 1.2 billion euros” in comparison with its preliminary forecast. An modification was tabled to this impact on Monday and attributes these extra bills to an quantity of reductions on medicines “significantly lower than expected”, specifies the textual content. Discounts permit you to pay much less for medicines than the official worth. At the tip of the yr, the laboratories then remit to the State the distinction between the official worth and the worth that was negotiated.

The slippage can be attributed to an “error of assessment” on the dynamics of drug spending, linked to the growing older of the inhabitants and the consumption of revolutionary, costlier medication, Élisabeth Doineau informed Agence France-Presse, social safety funds rapporteur within the Senate.

To Discover



Kangaroo of the day

Answer

According to the modification, the surplus can be “partially neutralized by the effect of the mechanism of the safeguard clause, which reduces it to 0.8 billion euros”, which suggests a better contribution from industrialists within the drugs. But in keeping with Geneviève Darrieussecq, the federal government intends to restrict this “slippage” after a “dialogue with manufacturers in order to find compensation mechanisms”. The monetary contribution of pharmaceutical laboratories, through the sector’s “safeguard clause”, would solely be “activated in the event of failure of the approach”, she assured.

His colleague and Minister of Public Accounts, Laurent Saint-Martin, then specified that the “different levers” below examine ought to make it attainable to “reduce the overrun compared to the trajectory presented” within the funds to 200 million euros. Social safety for 2025.